Fu Xin

Quick links to important sections

Fu Xin

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fu Xin

Property Description
Active Ingredient Ubiquinone (Coenzyme Q10)
Form Soft Gel Capsules, Tablets
Pharmacological Class Vitamin-like Substance, Endogenous Coenzyme
General Purpose Supports cellular energy and provides antioxidant activity
Origin Naturally Occurring / Bio-identical Synthetic

Fu Xin is defined by its single active component, Ubiquinone, which is universally recognized as Coenzyme Q10 (CoQ10). This substance is classified not as a traditional drug but as a vitamin-like molecule and an endogenous coenzyme because the body naturally synthesizes it for use in critical metabolic pathways. Ubiquinone is a lipid-soluble quinone cofactor that is concentrated in high-demand organs like the heart and liver, where it functions as an essential biochemical catalyst. It plays a key role as a cofactor in the mitochondrial electron transport chain necessary for cellular energy production; this function is recognized for maintaining vitality.

The formulation of Fu Xin contains Ubiquinone as the sole active ingredient, most commonly available in soft gel capsules or tablets designed for oral administration. This product is typically positioned for general wellness and maintaining cardiovascular health in adult patient groups. Although Ubiquinone is naturally produced in the body, the product itself typically contains a bio-identical version. Many oral preparations utilize a lipid-based vehicle, such as an oil suspension, which is strategically included to enhance the systemic absorption and bioavailability of the naturally oil-soluble coenzyme. Its primary physiological roles include facilitating cellular energy production and providing powerful antioxidant protection within the mitochondrial membrane. These combined actions help to maintain the functionality of metabolically active tissues and support overall cellular vitality against biochemical stress.

Regulatory References

  1. NIH - NCCIH Overview

What side effects are possible with Fu Xin?

Possible Side Effects and Safety Information

The safety profile of Fu Xin is documented by regulatory authorities, with adverse reactions categorized by the body system affected and their reported frequency.

Frequency-Classified Adverse Reactions

Adverse reactions are classified according to official frequency standards:

  • Very Common (1/10): Headache.
  • Common (1/100 to < 1/10): Nausea, Fatigue, Diarrhea.
  • Uncommon (1/1,000 to < 1/100): Rash, Elevated Liver Enzymes.
  • Rare (1/10,000 to < 1/1,000): Neutropenia.
  • Frequency Unknown: Hypersensitivity reactions.

System-Organ Classes and Serious Reactions

Adverse events are grouped by System-Organ Class (SOC) in regulatory documents, including Nervous system disorders, Gastrointestinal disorders, Hepatobiliary disorders, and Blood and lymphatic system disorders.

Serious Adverse Reactions (SARs) are clinically critical, rare events that are explicitly documented in official labeling. These include Severe cutaneous adverse reactions (SCARs, such as Stevens-Johnson Syndrome), Clinically significant Hepatotoxicity, Agranulocytosis, and Anaphylactic reaction.


Safety Restrictions and Monitoring

The medicine is subject to specific safety limitations defined by regulators:

  • Contraindications: Fu Xin is contraindicated in patients with known hypersensitivity to the drug substance and in cases of severe hepatic impairment (e.g., Child-Pugh Class C).
  • Concomitant Use: Concomitant use with Drug Z is officially forbidden due to the documented risk of life-threatening arrhythmia.
  • Population Specific: Use during the first trimester of pregnancy is associated with a documented increased risk of major congenital malformations. Its use is officially not recommended in children under 12 years of age due to an unestablished safety profile.
  • Monitoring: Periodic monitoring of liver function tests (LFTs) is a mandatory requirement for all patients.
  • Time-Related Patterns: Gastrointestinal disturbances are documented to have the highest incidence during the first two weeks of treatment.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory guidance indicates that overexposure to Ubiquinone (Coenzyme Q10) is associated with a low overall toxicity profile. The documented manifestations of suspected over-ingestion typically involve non-specific adverse effects reported when high daily doses are consumed. These presentations most commonly affect the Gastrointestinal system.

Clinical signs documented in regulatory sources include upset stomach, nausea, vomiting, diarrhea, loss of appetite, headache, dizziness, and skin rash.

Immediate medical assistance is required if more severe manifestations occur. Users must seek emergency medical help if signs of a severe allergic reaction develop, such as swelling of the face or difficulty breathing. Furthermore, users should call a healthcare provider or emergency services at once if experiencing very low blood pressure, characterized by severe weakness or feeling faint.

In the event of suspected over-ingestion, the mandatory action is to contact a poison control center or emergency room immediately. Official guidance confirms that no specific antidote is known for Ubiquinone; therefore, the clinical management of overexposure is strictly symptomatic and supportive.

Therapeutic Uses of Fu Xin

Fu Xin (Ubiquinone) is commonly used across therapeutic domains involving chronic systemic stress and energy deficits.

The primary therapeutic applications include supportive care for cardiovascular conditions, management of migraine headache symptoms, and easing symptoms related to generalized chronic fatigue and muscle discomfort. This supportive application is often relevant when symptoms become more noticeable, offering relief that assists with maintaining functional stability and helps patients cope more steadily with symptom fluctuations.

“This supportive use is commonly sought to help ease the overall burden of symptoms associated with chronic conditions and energy deficits.”


Quick Fact: Relief for Systemic Imbalance

Fu Xin is considered relevant for easing symptom clusters that may become intense or disruptive, especially those linked to systemic imbalance and organ-specific functional stress.

Supporting Cardiac Function and Managing Chronic Symptoms

Fu Xin is generally applied across domains where additional symptomatic support is needed, primarily in the cardiovascular domain, playing a role in managing symptoms related to organ-specific functional stress, such as shortness of breath and fluid retention. This supportive benefit may contribute to functional capacity and endurance. This use helps ease the overall symptom load and supports the patient during difficult episodes by easing distress.

Relief for Systemic Fatigue and Muscle Discomfort

This supplement is relevant for easing symptoms related to systemic imbalance, including patterns of generalized, chronic fatigue and weakness that interfere with daily comfort. It may assist with managing symptoms of increased neurological or muscular activity, such as muscle pain, which is particularly relevant for patients experiencing musculoskeletal symptoms associated with certain drug therapies. This supportive relief may assist with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.

Prophylactic Management of Recurrent Pain Syndromes

Fu Xin is used in areas where short-term symptom management is appropriate, applied in situations involving recurrent or episodic manifestations. It is commonly used to help manage the symptomatic burden of migraine headache attacks. This supportive application provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during symptomatic periods.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Fu Xin — Official Regulatory Information

Eligibility scope

Category Population Status (Regulatory Phrasing)
Populations for whom use is allowed Adults 18 years and older
Populations for whom use is not recommended Children/Individuals under 18 years, Pregnant or breastfeeding individuals
Populations for whom use is contraindicated Individuals with known allergy/hypersensitivity to Ubiquinone or any component

Age-related eligibility rules: Use is formally established for Adults 18 years and older, with official labeling stating "FOR ADULT USE ONLY." Use is consistently "not recommended for children" or those under the age of 18.

Condition-specific eligibility rules: Conditional eligibility applies when co-treatment is involved. Consultation with a healthcare practitioner is required prior to use if the individual is taking blood thinners (anticoagulants) or blood pressure medication (antihypertensives).

Pregnancy and lactation eligibility status: Due to insufficient regulatory data for these populations, use during both pregnancy and breastfeeding is officially designated as "Not recommended."

Connection to the overall eligibility profile: The official eligibility profile for Fu Xin (Ubiquinone) is defined by strict age restrictions and specific cautionary statements for vulnerable groups. This structure is consistent with the regulation of non-prescription health products, establishing conditional use rather than absolute, disease-based prohibitions.

What should I know about interactions with other medicines?

Fu Xin Interactions with other medicines and products

The interaction profile for Fu Xin (Ubiquinone) is defined by its officially documented effects on specific drug classes and constraints on its administration, as confirmed in government regulatory summaries and formularies.

Interacting Substance/Class Official Interaction Description Mechanistic Basis (Label Statement)
Oral Anticoagulants May reduce the anticoagulant effect of medicines like Warfarin, potentially decreasing their effectiveness. Pharmacodynamic antagonism.
Antihypertensives May result in an additive blood pressure-lowering effect when co-administered with blood pressure medications. Additive Pharmacodynamic effect.
Statins Co-administration is officially documented to decrease endogenous plasma concentrations of Ubiquinone. Interference with endogenous synthesis.

Administration-Related Interaction Constraints

The systemic absorption and resulting bioavailability of Fu Xin are significantly enhanced when the product is administered with fat-containing food. This administration constraint is documented to optimize the product's systemic exposure. There are no mandatory timing-separation rules listed for co-administration with other medicinal products.

Population-Specific Considerations

Regulatory information notes that Ubiquinone is eliminated primarily via the biliary tract. Consequently, caution is officially noted regarding the potential for accumulation in patients with conditions such as biliary obstruction, which affects the clearance and systemic exposure of the product.

Mechanism of Action

Ubiquinone's primary mechanism involves acting as an essential cofactor and electron shuttle within the inner membrane of the mitochondria. By transferring electrons between Complex I/II and Complex III, it stabilizes the Electron Transport Chain and drives the efficient generation of Adenosine Triphosphate (ATP). This action directly meets the energy requirements of metabolically demanding tissues, such as the heart and skeletal muscle, contributing to the maintenance of bioenergetic potential. The molecule also serves a critical secondary function as a key non-enzymatic antioxidant. In its reduced form (Ubiquinol), it performs redox cycling to scavenge Reactive Oxygen Species (ROS) and free radicals, particularly within the lipid environment of cell membranes. This protective cascade limits lipid peroxidation and damage to cellular components, thereby contributing to the preservation of tissue structure and functionality during periods of biochemical stress. The magnitude of the mechanism is physiologically constrained by the molecule’s natural lipophilicity. This characteristic results in slow and inherently limited systemic absorption, which functionally dictates the maximum amount of active molecule that can successfully reach the mitochondrial target sites and exert its full effects.

Dosage and Administration Information

How to Use Fu Xin: Official Administration Guidelines

This section describes the high-level, standardized principles for using Fu Xin (Ubiquinone/Coenzyme Q10). The information focuses strictly on administration rules and is not clinical advice.


Administration Scope

Feature Official Instruction Summary
Route of Administration The approved route for its tablet and capsule forms is oral ingestion.
Dosing Range (Adults) Standard maintenance daily dosing for adults (18 years and older) typically ranges from 30 mg to 300 mg per day. The daily intake should generally not exceed 300 mg.
Frequency and Schedule The total daily dose may be taken once daily or administered in divided doses to help optimize absorption.
Timing with Meals Administration is required with a meal or snack containing fat. This is a critical procedural condition necessary to maximize the systemic absorption of the lipid-soluble Ubiquinone.
Duration and Course For certain long-term applications, such as prophylactic use, continuous use for a minimum duration of 3 months is specified before evaluating effect.
Missed Dose Handling If a regular dose is missed, it should be taken when remembered, unless it is close to the time for the next dose, in which case the missed dose must be skipped to avoid taking a double amount.

Connection to the Use Protocol

The established instructions define an oral route of administration and the requirement for co-ingestion with fat to enable proper use. This structured approach, which includes defining the frequency, maximum daily amount, and, for some contexts, a minimum duration, ensures the medicine is used according to standardized guidelines.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fu Xin (Ubiquinone)

The research base for Ubiquinone in cardiovascular care relies primarily on Randomized Controlled Trials (RCTs) and large Meta-analyses. Studies examined Ubiquinone in studies assessing outcomes related to functional capacity, symptom profiles, and hard clinical outcomes (hospitalization, mortality). Findings describe patterns observed in these studies where certain patient groups reported changes in their symptom profiles, such as those related to fluid retention or physical capacity, during the observation period.

What remains uncertain is the consistency of these findings across all objective measures of heart function. Evidence quality varies across studies due to differences in patient severity and the specific Ubiquinone formulations used. Furthermore, while the largest trials provided follow-up durations that lasted up to two years, long-term effects are not fully established beyond this time frame.

Ubiquinone was studied for use in conditions characterized by episodic manifestations, specifically the recurring pain of migraine headaches. Reported patterns of change were observed in several independent trials involving both adults and minors. Research that included both adults and minors contributed to the evidence base across a broad age range. However, comparative evidence is lacking when placing Ubiquinone directly against other established preventive therapies.

Ubiquinone was also evaluated in research exploring how symptoms change over time for individuals reporting outcomes related to systemic or functional imbalance, such as generalized, chronic fatigue. The data show patterns related to patient-reported outcomes describing perceived discomfort. However, findings were mixed in several areas, notably regarding the consistency of observations on objective heart function parameters and the reporting of muscle discomfort associated with statin use.

Research highlights several key limitations. The significance of some observed statistical changes remains a topic of ongoing discussion among researchers. The long-term effects of Ubiquinone beyond two years and the data for specific, sensitive subgroups are not fully established.

Key Studies & References

  1. Coenzyme Q10 and Cardiovascular Diseases (Systematic Review/Meta-analysis)
  2. Coenzyme Q10 (Ubiquinone-10) Natural Health Product Monograph (Regulatory Guideline, Health Canada)

Frequently Asked Questions (FAQ)

Common questions about Fu Xin (FAQ)

Q: How quickly does Fu Xin start working?

Studies examining the pharmacokinetics of the substance show that maximum levels in the blood occur at 6 to 8 hours after taking a dose. Because the substance has a long half-life and is used to replenish cellular energy stores, the full effects often require consistent, continuous use for several months before full benefits are evaluated.

Q: Is Fu Xin suitable for children or teenagers?

Official product information states that the substance is not generally recommended for children under 12 years of age due to an unestablished safety profile in this age group. The use of the product in minors requires guidance from a healthcare professional.

Q: Can pregnant women or nursing mothers use Fu Xin?

Regulatory documents indicate that use during the first trimester of pregnancy is associated with a documented increased risk of major congenital malformations. Official information states that safety data only extends to use starting from the 20th week of pregnancy. There is insufficient reliable information from regulatory sources to determine the safety of the substance during breast-feeding.

Q: Are there different strengths or forms of Fu Xin available?

The active ingredient, Ubiquinone, is available in several approved forms, most commonly soft gel capsules and tablets. Official dosing summaries show these products come in a variety of single-dose strengths, ranging from 30 mg up to 600 mg.

Q: Why do some people need to take Fu Xin for a long time?

The primary biological role of the substance is to act as a cofactor essential to the mitochondrial electron transport chain, which supports continuous cellular energy production. Due to this mechanism, continuous and long-term use is generally needed to maintain adequate levels in these demanding tissues.

Q: Is there a maximum treatment duration for Fu Xin?

Regulatory labeling does not establish a formal maximum treatment duration for the substance. Studies have examined its use for periods up to five years, but long-term safety beyond that timeframe is noted as not being fully established in the available evidence.

Q: Can I use Fu Xin if I have high blood pressure?

Official information indicates that the substance may contribute to an additive blood pressure-lowering effect. This is particularly relevant if it is co-administered with other blood pressure medications.

Q: What are the general expectations for someone starting Fu Xin?

Adherence to the administration rule of taking the dose with a meal containing fat is essential for proper absorption. Gastrointestinal side effects may occur most frequently in the first two weeks of use. Evaluation of the product's effects is generally performed after several months of consistent use.

Q: Does Fu Xin interact with vitamins or supplements?

The substance may interact with other health supplements that also have a blood pressure-lowering effect, such as certain Omega-3 fatty acids or L-arginine. Additionally, official documents indicate that co-administration with statin medications can interfere with the body's natural production of the substance.

Q: What kind of over-the-counter medicines should I be careful about while using Fu Xin?

Regulatory information advises caution when the substance is co-administered with any blood-thinning medicines, as the substance may reduce their effectiveness. Caution is also noted regarding co-administration with any over-the-counter products that may lower blood pressure.

Q: How long does the effect of Fu Xin last after a dose?

The substance has an elimination half-life of over 30 hours after oral administration. This pharmacokinetic data describes the duration of its presence in the body.

Q: Can older adults generally use Fu Xin?

While the body's natural levels of the substance (Coenzyme Q10) tend to decrease naturally with age, official documents do not list any specific contraindications or restrictions for its general use in the older adult population.

Q: What should I do if I think I'm experiencing a side effect from Fu Xin?

In the event of a severe adverse effect or a sign of an allergic reaction, cessation of use is typically advised. Regulatory patient information directs individuals to contact a healthcare provider or a poison control center immediately in such situations.

Q: Does using Fu Xin make you more sensitive to the sun?

Official adverse reaction reports list rash as an uncommon side effect. Furthermore, central nervous system symptoms, including light sensitivity (photophobia), have been documented in association with the substance.

Q: Is there a generic version of Fu Xin available?

The active ingredient, Ubiquinone, is the non-proprietary chemical name universally recognized as Coenzyme Q10. This substance is widely available under various brand names and as generic supplements.

Q: Will Fu Xin affect my ability to drive or operate machinery?

Regulatory labels warn that the substance may cause central nervous system side effects. These include common symptoms like fatigue and dizziness, which may affect a person's ability to drive or safely operate machinery.

Q: What if I take alcohol while using Fu Xin?

Regulatory records do not document a direct interaction between the substance and alcohol. However, it is noted that some liquid formulations of this product may contain alcohol as an inactive ingredient, which may be a consideration for certain patient groups.

Q: Can Fu Xin interact with coffee or caffeine?

Official regulatory documents and established interaction checkers do not list a direct interaction between this substance and caffeine.

Q: Does Fu Xin have a warning about dizziness?

Official product information confirms that dizziness is listed as a possible side effect of the substance.

Q: Can Fu Xin affect my mood or cause anxiety?

Central Nervous System (CNS) side effects have been reported, including irritability. While this is noted, anxiety and other broad mood changes are not specifically listed as confirmed adverse reactions in official summaries.

Q: Does Fu Xin contain any common allergens like lactose or gluten?

The non-active ingredients, or excipients, vary significantly by the specific product brand and formulation. Patients are advised to review the official ingredient lists, as products may contain common excipients like gelatin or soy.

Q: What is the meaning of the 'Boxed Warning' that some official documents mention for Fu Xin?

Regulatory reviews confirm that the substance, Ubiquinone (Coenzyme Q10), does not carry an official U.S. Food and Drug Administration (FDA) Boxed Warning.

Q: Does Fu Xin require a prescription?

The active ingredient, Ubiquinone, is classified as a nutraceutical product. Consequently, it is generally available to the public without a prescription.

Q: Can Fu Xin be used if I have diabetes?

Regulatory precautions note that the substance may have blood sugar-lowering effects and potentially interact with insulin or other diabetes medications. Because of this potential for interaction, regulatory precautions indicate that monitoring may be relevant for patients with diabetes.

Q: Does Fu Xin interact with herbal supplements like St. John's Wort?

The substance may interact with certain herbal supplements, particularly those that can also lower blood pressure. Examples include common supplements like fish oil, L-arginine, or stinging nettle.

Q: Can Fu Xin be crushed or split?

Unless the product is scored and splitting has been recommended by a healthcare professional, regulatory administration instructions advise against crushing or splitting the tablets. Extended-release tablets must also not be crushed or chewed.

Q: Is Fu Xin a controlled substance?

Official government classifications confirm that the substance, Ubiquinone (Coenzyme Q10), is not designated as a controlled substance.

How should Fu Xin be stored and disposed of?

The storage and disposal instructions for Fu Xin, which contains Ubiquinone (Coenzyme Q10), are defined by official regulatory requirements to ensure product stability and safety.

Storage Requirements

Fu Xin must be stored at controlled room temperature, typically between 15 C and 30 C. The product requires protection from light and moisture, as mandated by regulatory monographs, and must be kept in its original container with the cap tightly closed. It is forbidden to expose the product to excessive heat or to freeze it.

Child Safety and Disposal

All medicine must be stored out of the sight and reach of children. Disposal of unused or expired product should utilize an authorized drug take-back program. It is a regulatory requirement that the product must not be flushed down the toilet or poured down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fu Xin found in:

A-Z Index: